Naseripour M - Search Results

1

Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma.

Shields CL, Naseripour M, Shields JA, Eagle RC Jr. Shields CL, et al. Among authors: naseripour m. Ophthalmology. 2002 Nov;109(11):2129-33. doi: 10.1016/s0161-6420(02)01239-3. Ophthalmology. 2002. PMID: 12414427

2

Molecular evidence of human papillomaviruses in the retinoblastoma tumor.

Javanmard D, Moein M, Esghaei M, Naseripour M, Monavari SH, Bokharaei-Salim F, Sadeghipour A. Javanmard D, et al. Among authors: naseripour m. Virusdisease. 2019 Sep;30(3):360-366. doi: 10.1007/s13337-019-00540-7. Epub 2019 Jul 24. Virusdisease. 2019. PMID: 31803802 Free PMC article.

3

Melatonin As a Modulator of Degenerative and Regenerative Signaling Pathways in Injured Retinal Ganglion Cells.

Juybari KB, Hosseinzadeh A, Ghaznavi H, Kamali M, Sedaghat A, Mehrzadi S, Naseripour M. Juybari KB, et al. Among authors: naseripour m. Curr Pharm Des. 2019;25(28):3057-3073. doi: 10.2174/1381612825666190829151314. Curr Pharm Des. 2019. PMID: 31465274 Review.

4

Pseudohypopyon of orange pigment overlying a stable choroidal nevus.

Naseripour M, Shields CL, Shields JA, Guyer DR. Naseripour M, et al. Am J Ophthalmol. 2001 Sep;132(3):416-7. doi: 10.1016/s0002-9394(01)00992-8. Am J Ophthalmol. 2001. PMID: 11530063

5

Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.

Shields CL, Naseripour M, Shields JA. Shields CL, et al. Among authors: naseripour m. Am J Ophthalmol. 2002 May;133(5):601-6. doi: 10.1016/s0002-9394(02)01400-9. Am J Ophthalmol. 2002. PMID: 11992855 Clinical Trial.

6

Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.

Shields CL, Naseripour M, Cater J, Shields JA, Demirci H, Youseff A, Freire J. Shields CL, et al. Among authors: naseripour m. Ophthalmology. 2002 Oct;109(10):1838-49. doi: 10.1016/s0161-6420(02)01181-8. Ophthalmology. 2002. PMID: 12359604

7

Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.

Shields CL, Naseripour M, Shields JA, Freire J, Cater J. Shields CL, et al. Among authors: naseripour m. Am J Ophthalmol. 2003 May;135(5):648-56. doi: 10.1016/s0002-9394(02)02241-9. Am J Ophthalmol. 2003. PMID: 12719072

8

Bilateral Pseudomonas aeruginosa endophthalmitis following bilateral simultaneous cataract surgery.

Kashkouli MB, Salimi S, Aghaee H, Naseripour M. Kashkouli MB, et al. Among authors: naseripour m. Indian J Ophthalmol. 2007 Sep-Oct;55(5):374-5. doi: 10.4103/0301-4738.33825. Indian J Ophthalmol. 2007. PMID: 17699948 Free PMC article.

9

Topical antiglaucoma medications and lacrimal drainage system obstruction.

Kashkouli MB, Rezaee R, Nilforoushan N, Salimi S, Foroutan A, Naseripour M. Kashkouli MB, et al. Among authors: naseripour m. Ophthalmic Plast Reconstr Surg. 2008 May-Jun;24(3):172-5. doi: 10.1097/IOP.0b013e3181706829. Ophthalmic Plast Reconstr Surg. 2008. PMID: 18520829 Clinical Trial.

10

Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.

Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M. Naseripour M, et al. Br J Ophthalmol. 2009 Jan;93(1):28-32. doi: 10.1136/bjo.2008.139410. Epub 2008 Oct 24. Br J Ophthalmol. 2009. PMID: 18952647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results